Cardiometabolic-based chronic disease: adiposity and dysglycemia drivers of heart failure

Eduardo Thadeu de Oliveira Correia, Jeffrey I. Mechanick, Letícia Mara dos Santos Barbetta, Antonio José Lagoeiro Jorge, Evandro Tinoco Mesquita

Research output: Contribution to journalReview articlepeer-review

6 Scopus citations

Abstract

Heart failure (HF) is a complex clinical syndrome, associated with high rates of mortality, hospitalization, and impairment of quality of life. Obesity and type 2 diabetes are major cardiometabolic drivers, represented as distinct stages of adiposity- and dysglycemia-based chronic disease (ABCD, DBCD), respectively, and leading to cardiometabolic-based chronic disease (CMBCD). This review focuses on one aspect of the CMBCD model: how ABCD and DBCD influence genesis and progression of HF phenotypes. Specifically, the relationships of ABCD and DBCD stages with structural and functional heart disease, HF risk, and outcomes in overt HF are detailed. Also, evidence-based lifestyle, pharmacological, and procedural interventions that promote or reverse cardiac remodeling and outcomes in individuals at risk or with HF are discussed. In summary, driver-based chronic disease models for individuals at risk or with HF can expose prevention targets for more comprehensive interventions to improve clinical outcomes. Future randomized trials that investigate structured lifestyle, pharmacological, and procedural therapies specifically tailored for the CMBCD model are needed to develop personalized care plans to decrease HF susceptibility and improve outcomes.

Original languageEnglish
Pages (from-to)47-61
Number of pages15
JournalHeart Failure Reviews
Volume28
Issue number1
DOIs
StatePublished - Jan 2023

Keywords

  • Cardiometabolic
  • Diabetes
  • Heart failure
  • Insulin resistance
  • Obesity
  • Overweight

Fingerprint

Dive into the research topics of 'Cardiometabolic-based chronic disease: adiposity and dysglycemia drivers of heart failure'. Together they form a unique fingerprint.

Cite this